Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources
NCT01956032 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15
Last updated 2016-02-23
Summary
The purpose of this study was to evaluate the use of resources during titration of Duodopa at home.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Eva Dahl, MD · AbbVie
Eligibility
- Min Age
- 18 Years
- Max Age
- 99 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-11-30
- Completion
- 2014-11-30
More Related Trials
-
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
NCT01484990 ·Status: COMPLETED ·Phase: PHASE1
-
A Post Marketing Observational Study of Activities of Daily Living in Advanced Parkinson's Disease Patients With Early Troublesome Motor Fluctuations and Treated With Duodopa - a Multi-country Study
NCT01747655 ·Status: COMPLETED
-
Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion
NCT03602924 ·Status: UNKNOWN
-
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
NCT00134966 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
NCT00143026 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)
NCT02799381 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
NCT01291537 ·Status: COMPLETED ·Phase: PHASE2
-
Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
NCT06234995 ·Status: RECRUITING ·Phase: PHASE4
-
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
NCT00129181 ·Status: COMPLETED ·Phase: NA
-
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
NCT02611713 ·Status: COMPLETED
-
Neural Signatures of Parkinson's Disease
NCT01990313 ·Status: COMPLETED ·Phase: NA
-
Parkinson's KinetiGraph as Tool for DBS Eligibility Assessment
NCT02509325 ·Status: COMPLETED
-
Evaluation of Remote DBS Programming.
NCT05193825 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
NCT01736176 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Outcomes for Deep Brain Stimulation
NCT03992625 ·Status: RECRUITING
-
The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation
NCT05901350 ·Status: COMPLETED ·Phase: NA
-
Transdermal Rotigotine User Surveillance Study
NCT00599339 ·Status: COMPLETED
-
Effects of Deep Brain Stimulation for the Treatment of Parkinson's Disease
NCT00358189 ·Status: COMPLETED
-
Effects of Deep Brain Stimulation on Motor, Mood, and Cognitive Symptoms in Parkinson's Disease
NCT00360009 ·Status: COMPLETED ·Phase: NA
-
The Impact of Exercise on Subthalamic Nucleus Neural Activity in Parkinson's Disease
NCT05905302 ·Status: COMPLETED ·Phase: NA
-
Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment
NCT02967250 ·Status: COMPLETED ·Phase: PHASE1
-
Intraoperative Investigation of a Directional Lead and Local Field Potentials for the Optimization of Stimulation Efficacy
NCT03630302 ·Status: COMPLETED
-
Personalized Real-Time DBS and PD Mechanisms
NCT06013956 ·Status: RECRUITING ·Phase: PHASE4
-
Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa
NCT01683253 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
NCT02112812 ·Status: COMPLETED ·Phase: NA